Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
Conditions
Depression
What is the purpose of this trial?
This study aims to examine the antidepressant efficacy of riluzole, employing a randomized, double-blind, placebo-controlled, adjunctive trial in treatment-resistant major depressive disorder (TRD).
Participation Guidelines
- Age:
- 18 Years - 65 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Yale University
- Dates:
- June 2011
- Last Updated:
- March 16, 2012
- Study HIC#:
- 0903004917
Clinicaltrials.gov ID: NCT01204918
